We've detected an Ad Blocker in your browser.
Please disable or pause the Ad Blocker and refresh the page to be able to register and access the website normally.
Register Free to Attend Online
Millbrook Medical Conferences, in association with Abbott and Radcliffe Cardiology, proudly introduce the 6th annual CORE meeting, brought to you live and in person from the Royal College of Physicians, London.
CORE 2022 will assemble world renowned experts to discuss and demonstrate how we can optimise PCI outcomes, together as a community. Innovative lectures and live cases will address the appropriate treatment pathway for patients in 2022. We’ll explore how to further improve patient outcomes by looking at the latest clinical evidence, cutting-edge techniques and beyond the intervention.
Chairs: Jonathan Hill and Adrian Banning
Panel: Kalpa De Silva, Angela McInerney, Stanislaw Bartus
Panel: Jacob Odenstedt, Sundeep Kalra, Ziad Ali
Mater Private Hospital – Colm Hanratty, Mark Kennedy
Aarhus University Hospital – Evald Christiansen, Lars Jakobsen, Niels Holm
Chairs: Ziad Ali and Adrian Banning
Panel: Andy Ladwiniec, Thomas Engstrom, Ingibjorg Gudmundsdottir
Panel: Vijay Kunadian, Elliot Smith, Jacek Legutko
St George’s Hospital – James Spratt, Claudia Cosgrove
Angio Based: Staged Complex PCI Case: Aarhus University Hospital – Lars Jakobsen, Niels Holm, Christian Juhl Terkelsen
Chairs: Colm Hanratty and Evald Christiansen
Panel: Peter O’Kane, Sean Gallagher, Shrilla Banerjee
Panel: Stephen Hoole, Tom Keeble, Ahmed Elghamaz
Aarhus University Hospital - Evald Christiansen, Lars Jakobsen, Niels Holm
Mater Private Hospital – Robert Byrne, Mark Kennedy
Chairs: Adrian Banning and James Spratt
Panel: Rasha Al-Lamee, Matthias Gotberg, Christopher Baker
Charalambos Antoniades, Nilesh Pareek
Panel: Andrew Lucking, Abdul Mozid, Claudia Cosgrove
Royal Brompton Hospital - Jonathan Hill, Sundeep Kalra
London Bridge Hospital - Julian Strange, Simon Wilson
St George’s University Hospital NHS Trust, London, UK
Prof James Spratt is a Consultant Cardiologist and Professor of Interventional Cardiology in the Cardiology Care Group and the Cardiovascular Clinical Academic Group at St George's Hospital NHS Foundation Trust in London. He is one of a small number of interventional cardiologists in the world pioneering techniques to unblock coronary arteries with percutaneous coronary intervention.
John Radcliffe Hospital, Oxford, UK
Prof Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention. He is past-president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Prof Banning has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.
Aarhus University Hospital, DK
Prof Evald Høj Christiansen is an Associate Professor in the Cardiology Department of Aarhus University Hospital. He is an interventional cardiologist with 15 years of experience in the field. His main interest is chronic total occlusions, bifurcations, coronary imaging, physiologic evaluations of coronary artery disease, and TAVR. He has performed a series of studies in this area and has conducted many clinical trials.
Royal Brompton Hospital, London, UK
Dr Jonathan Hill is a Consultant Interventional Cardiologist, Chair Revascularisation Group at the Royal Brompton Hospital, London. He trained in Cambridge and Edinburgh Universities. He undertook interventional training at London Chest Hospital and Interventional research at the National Institute of Health. His specialist interests are imaging and vascular repair and healing following coronary intervention. His main clinical interest is in complex coronary disease and chronic total occlusion management. He is a keen proponent of the concept of precision PCI and the integration of OCT into complex diseases management. He has been involved with the development of Complete Revascularisation initiatives and the CHIP PCI movement. His research background at the National Institutes of Health centred around stem and progenitor cell translational research. His current research interests are in early phase clinical trials with intravascular lithotripsy and coronary sinus reducer implantation.
Mater Private Hospital Dublin, Ireland
Dr Colm Hanratty graduated from Queen’s University Belfast in 1992. He was awarded his MRCPI from Edinburgh University in 1995 and MD from Queen’s University Belfast in 2000. He completed his general medical and cardiology training at Belfast City Hospital and Royal Victoria Hospital Belfast, Northern Ireland. His fellowship in Interventional Cardiology was in Sydney, Australia, followed by further specialist Cardiology training in Belfast City and Antrim Area Hospitals, Northern Ireland. In 2003 Dr. Hanratty was appointed as an Interventional Cardiologist in Belfast City Hospital. In February 2020 he joined the Mater Private Hospital Dublin, where he took up the role as Director of Cath Lab.
In partnership with: